Transfusion-Associated Microchimerism in Individuals Receiving a Blood

Status Completed

Clinical Trial Summary

Individuals who experience a traumatic injury often have a significant amount of blood loss and may require a blood transfusion. In some individuals who receive a blood transfusion, white blood cells from the donor's blood may remain in the body for years, a condition known as microchimerism. This study will examine the reasons why microchimerism occurs in some blood transfusion recipients and not others.

Clinical Trial Description

Approximately 20% of individuals who suffer a traumatic injury require a blood transfusion; of these, 10% to 15% experience a condition known as transfusion-associated microchimerism. This occurs when white blood cells, or leukocytes, from the donor's blood persist in the recipient long after the transfusion occurs. The genetically distinct donor cells can remain in the individual for decades, and may account for as many as 4% of the white blood cells in the recipient's body. This suggests that the donor cells are tolerated by the recipient's immune system. The purpose of this study is to examine the specific factors that predispose some blood transfusion recipients to develop microchimerism.

In this study, blood samples will be collected from injured individuals who arrive at the University of California at Davis Medical Center. Individuals who receive a blood transfusion, as well as a control group of individuals who do not receive a transfusion, will be approached to enroll in the study. Individuals who agree to participate will have their blood collected at Days 7, 14, and 28 and Months 3 and 6. Study researchers will analyze the blood for evidence of microchimerism. Participants with microchimerism will undergo additional blood collection at Months 12, 18, 24, 30, and 36. Information will be collected from all participants on health status, injury characteristics, hospital care, blood transfusion details, and blood donor characteristics. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00400192
Study type	Observational
Source	Blood Systems Research Institute
Contact
Status	Completed
Phase	N/A
Start date	November 2006
Completion date	July 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04554212` - Blood Flow Restriction Training After Patellar INStability	N/A
Suspended	`NCT02932176` - Machine Learning for Handheld Vascular Studies
Recruiting	`NCT04803253` - Study of the Social and Professional Reintegration Improvements Using a Set of Solutions for Upper Limb Amputation	N/A
Completed	`NCT00116337` - Spinal Cord Stimulation to Restore Cough	N/A
Completed	`NCT03463720` - Outcome for Patients With War-Associated Extremity Wound Infection	N/A
Completed	`NCT03113253` - TRANexamic Acid to Reduce Bleeding in BURN Surgery	Phase 4
Not yet recruiting	`NCT05492903` - COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)	N/A
Terminated	`NCT02909231` - One-year Patient Reported Outcomes Following Hospitalization for Trauma	N/A
Completed	`NCT02432456` - Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients	Phase 4
Completed	`NCT02744144` - Wound Bacterial Microbiota and Their Antibiotic Resistance	N/A
Completed	`NCT02266771` - Impact of V.A.C. Veraflo Therapy in Wounds Requiring Debridement Within an Orthopedic Practice	N/A
Completed	`NCT02394821` - Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide	Phase 3
Not yet recruiting	`NCT01665963` - Efficacy of TopClosure(C)System in Healing Complicated Pacemaker Wounds	N/A
Completed	`NCT00151112` - Comparison of Two Different Procedures for Plexus Anesthesia	N/A
Not yet recruiting	`NCT03872544` - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting	`NCT04596124` - Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze	N/A
Recruiting	`NCT05800834` - Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds	Phase 2
Enrolling by invitation	`NCT03880188` - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Terminated	`NCT04775316` - Prospective, International, Multicenter, Observational Study to Evaluate the Clinical Performance and Safety of a Silicone-coated Transparent Postoperative Dressing
Enrolling by invitation	`NCT03312504` - Implementing a School Prevention Program to Reduce Injuries Through Neuromuscular Training	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Transfusion-Associated Microchimerism in Individuals Receiving a Blood Transfusion After a Traumatic Injury

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms